Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform

BACKGROUND: Breast cancer is the most common invasive cancer among women. Currently, there are only a few models used for therapy selection, and they are often poor predictors of therapeutic response or take months to set up and assay. In this report, we introduce a microfluidic OrganoPlate® platfor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Lanz, Henriette L., Saleh, Anthony, Kramer, Bart, Cairns, Junmei, Ng, Chee Ping, Yu, Jia, Trietsch, Sebastiaan J., Hankemeier, Thomas, Joore, Jos, Vulto, Paul, Weinshilboum, Richard, Wang, Liewei
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Technical Advance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5668957/
https://ncbi.nlm.nih.gov/pubmed/29096610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3709-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars